KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Long-Term Debt Issuances (2016 - 2023)

Amgen has reported Long-Term Debt Issuances over the past 12 years, most recently at $4.0 billion for Q4 2023.

  • Quarterly results put Long-Term Debt Issuances at $4.0 billion for Q4 2023, up 21131.58% from a year ago — trailing twelve months through Sep 2024 was $4.0 billion (down 83.18% YoY), and the annual figure for FY2023 was $27.8 billion, up 301.46%.
  • Long-Term Debt Issuances for Q4 2023 was $4.0 billion at Amgen, up from $1.0 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for AMGN hit a ceiling of $23.8 billion in Q1 2023 and a floor of -$88.0 million in Q3 2020.
  • Median Long-Term Debt Issuances over the past 4 years was $3.0 billion (2022), compared with a mean of $3.7 billion.
  • Biggest five-year swings in Long-Term Debt Issuances: crashed 1800.0% in 2022 and later soared 21131.58% in 2023.
  • Amgen's Long-Term Debt Issuances stood at -$88.0 million in 2020, then surged by 98.86% to -$1.0 million in 2021, then crashed by 1800.0% to -$19.0 million in 2022, then soared by 21131.58% to $4.0 billion in 2023.
  • The last three reported values for Long-Term Debt Issuances were $4.0 billion (Q4 2023), $1.0 million (Q3 2023), and -$18.0 million (Q2 2023) per Business Quant data.